000			01953 a2200493 4500
005			20250517233657.0
264		0	_c20190111
008			201901s 0 0 eng d
022			_a1876-4479
024	7		_a10.1093/ecco-jcc/jjy011 _2doi
040			_aNLM _beng _cNLM
100	1		_aPanés, Julián
245	0	0	_aPast, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. _h[electronic resource]
260			_bJournal of Crohn's & colitis _cAug 2018
300			_aS633-S640 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aCell Adhesion Molecules
650	0	4	_aCell Communication _xdrug effects
650	0	4	_aChemotaxis, Leukocyte _xdrug effects
650	0	4	_aEndothelial Cells _xphysiology
650	0	4	_aFingolimod Hydrochloride _xtherapeutic use
650	0	4	_aGastrointestinal Agents _xpharmacology
650	0	4	_aGastrointestinal Tract _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunoglobulins
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aIndans _xtherapeutic use
650	0	4	_aInflammatory Bowel Diseases _xdrug therapy
650	0	4	_aIntegrins _xantagonists & inhibitors
650	0	4	_aIntercellular Adhesion Molecule-1
650	0	4	_aLeukocytes _xphysiology
650	0	4	_aLysophospholipids _xagonists
650	0	4	_aMucoproteins _xantagonists & inhibitors
650	0	4	_aNatalizumab _xtherapeutic use
650	0	4	_aOxadiazoles _xtherapeutic use
650	0	4	_aPhosphorothioate Oligonucleotides _xtherapeutic use
650	0	4	_aReceptors, Lysosphingolipid _xagonists
650	0	4	_aSphingosine _xagonists
700	1		_aSalas, Azucena
773	0		_tJournal of Crohn's & colitis _gvol. 12 _gno. suppl_2 _gp. S633-S640
856	4	0	_uhttps://doi.org/10.1093/ecco-jcc/jjy011 _zAvailable from publisher's website
999			_c28758944 _d28758944